Compare LYFT Inc (LYFT) vs Novavax Inc (NVAX) Price & Performance

LYFT IncTrade

Novavax IncTrade

Price performance (Past 24H)

Key statistics

LYFT Inc vs Novavax Inc — how do they compare? LYFT Inc trades at $17.5 (market cap $6.53B), while Novavax Inc trades at $7.97 (market cap $1.30B). The key difference: LYFT Inc is far larger — about 5× Novavax Inc's market cap. Which is the better fit depends on your goals.

	LYFT	NVAX
Market Cap	$6.53B	$1.30B
Sector	Industrials	Health
52-Week High	$24.57	$11.19
52-Week Low	$12.65	$6.22
Enterprise Value	$6.00B	$879.40M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LYFT

Lyft is a unique mobility platform, not just a smaller Uber, with a distinct business model.Seeking Alpha · 18 hours agoNeutral Hertz shares jump 25% after strong Q2 earnings beat and rally fueled by retail investors.24/7 Wall Street · 19 hours agoBullish Lyft shows strong growth and cash flow, making it a value buy despite stock underperformance.Seeking Alpha · 1 day agoBullish View details →

NVAX

View details →

About LYFT Inc

Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.